http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1320446-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5df81aef22519e5b2645b5c1696bae24 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00 |
| filingDate | 1988-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1993-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfe1cf39b6143ff2a73dc54f2d661d2b |
| publicationDate | 1993-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1320446-C |
| titleOfInvention | Modulation of lymphokine-resistant cellular states by dsrnas |
| abstract | ABSTRACT OF THE DISCLOSURE Tumor cells sub- or non-responding to the antiproliferative effects of lymphokines, notably the interferons and the interleukins, are rendered lymphokine-responsive by exposing the tumor cells to exogenous mismatched dsRNAs. These dsRNAs themselves modulate cell growth of susceptible tumors towards normalization and loss of cancerous cell phenotype. |
| priorityDate | 1988-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 210.